title: Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30.
authors.affiliation: Infections & Immunoepidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA. goedertj@mail.nih.gov.
authors.forename: Colleen
authors.initials: C
authors.lastname: Pelser
authors.forename: Jaap
authors.initials: J
authors.lastname: Middeldorp
authors.forename: Sam M
authors.initials: SM
authors.lastname: Mbulaiteye
authors.forename: Carmela
authors.initials: C
authors.lastname: Lauria
authors.forename: Angelo
authors.initials: A
authors.lastname: Messina
authors.forename: Enza
authors.initials: E
authors.lastname: Viviano
authors.forename: Nino
authors.initials: N
authors.lastname: Romano
authors.forename: Francesco
authors.initials: F
authors.lastname: Vitale
authors.forename: James J
authors.initials: JJ
authors.lastname: Goedert